TLR9 Antibody [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # AF3658B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Flow Cytometry, CyTOF-ready
Label
Biotin
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human TLR9
Asn64-Glu189
Accession # Q9NR96
Asn64-Glu189
Accession # Q9NR96
Specificity
Detects human TLR9 in direct ELISAs. In direct ELISAs, approximately 75% cross-reactivity with recombinant mouse TLR9 is observed, and less than 1% cross-reactivity with recombinant human (rh) TLR1, rhTLR2, rhTLR3, rhTLR4, rhTLR5, rhTLR7, rhTLR8, and rhTLR10 is observed.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for TLR9 Antibody [Biotin]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TLR9
Long Name
Toll-like Receptor 9
Alternate Names
CD289
Gene Symbol
TLR9
Additional TLR9 Products
Product Documents for TLR9 Antibody [Biotin]
Product Specific Notices for TLR9 Antibody [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...